SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-07-247406
Filing Date
2007-11-14
Accepted
2007-11-14 16:29:37
Documents
7
Period of Report
2007-06-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-Q d10qa.htm 10-Q/A 806260
2 FORM OF NOTICE OF GRANT OF STOCK AND STOCK OPTION AGREEMENT dex102.htm EX-10.2 71601
3 FORM OF NOTICE OF GRANT AND STOCK OPTION AGREEMENT (FOR OUTSIDE DIRECTORS) dex103.htm EX-10.3 71573
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) dex311.htm EX-31.1 5985
5 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) dex312.htm EX-31.2 5920
6 CERTIFICATION BY THE CEO AND THE CFO AS REQUIRED BY RULE 13A-14(B) dex321.htm EX-32.1 3396
7 GRAPHIC g52643logo.jpg GRAPHIC 10312
  Complete submission text file 0001193125-07-247406.txt   980601
Mailing Address 1400 SEAPORT BLVD. REDWOOD CITY CA 94063
Business Address 1400 SEAPORT BLVD. REDWOOD CITY CA 94063 650-454-1000
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-19756 | Film No.: 071245312
SIC: 2836 Biological Products, (No Diagnostic Substances)